Prokocimer Philippe 4
4 · Trius Therapeutics Inc · Filed Mar 12, 2012
Insider Transaction Report
Form 4
Prokocimer Philippe
Chief Medical Officer
Transactions
- Award
Stock Option (right to buy)
2012-03-08+90,000→ 90,000 totalExercise: $4.80Exp: 2022-03-07→ Common Stock (90,000 underlying)
Footnotes (1)
- [F1]The option vests in 48 successive equal monthly installments over the four year period beginning on March 8, 2012.